MEDICAL CODING TRAINING
#NO:1 MEDICAL CODING TRAINING.
Transorze Solutions is a reputed national institution established in Trivandrum, Kerala, India since 2010, and is totally dedicated to providing the services of Medical Transcription, Medical Coding, Medical Scribing training. Transorze is an ISO 9001:2015 certified company for delivering high quality "Healthcare training and placement services. Transorze is in the process of continuous evolution and plans to expand its operations by establishing more knowledge centers in Kerala and rest-of-India.
NO:1 & BEST MEDICAL CODING TRAINING IN KOCHI #TRANSORZE
MEDICAL CODING
Medical Coders and Billers play an important role in the financial success of private practices and other healthcare facilities. The greater the expertise of the Medical Coder in identifying relevant diagnoses for patient encounters..
Medical coding is the transformation of healthcare diagnosis, procedures, medical services, and equipment into universal medical alphanumeric codes. A medical coder is responsible for assigning the correct code to describe the type of service a patient will receive.
GAUCHER DISEASE
Medical coding is the transformation of healthcare diagnosis, procedures, medical services, and equipment into universal medical alphanumeric codes. A medical coder is responsible for assigning the correct code to describe the type of service a patient will receive
E75.22 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.The 2021 edition of ICD-10-CM E75.22 became effective on October 1, 2020.This is the American ICD-10-CM version of E75.22 - other international versions of ICD-10 E75.22 may differ.
There are 3 types of Gaucher disease:
- Type 1. This is the most common type of Gaucher disease. It affects about 90% of people with the disease. If you have type 1, you don’t have enough platelets in your blood. This can make you bruise easily and feel very tired (fatigued). Your symptoms can start at any age. You might have an enlarged liver or spleen. You may also have kidney, lung, or skeletal problems.
- Type 2. This form of the disease affects babies by age 3 to 6 months. It is fatal. In most cases children don’t live beyond 2 years old.
- Type 3. Symptoms include skeletal problems, eye movement disorders, seizures that become more obvious over time, blood disorders, breathing problems, and liver and spleen enlargement.
- An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (glucosylceramidase) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the mononuclear phagocyte system. The characteristic gaucher cells, glycosphingolipid-filled histiocytes, displace normal cells in bone marrow and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.
- An inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia.
- Autosomal recessive disorder caused by deficiency of the enzyme glucocerebrosidase featuring the pathological storage of glycosylceramide in mononuclear phagocytes; the most common subtype is the non-neuronopathic form, a slowly progressive condition characterized by hepatosplenomegaly and skeletal deformities; the neuronopathic forms are divided into infantile and juvenile forms; the infantile form presents at 4-5 months of age with anemia, loss of cognitive gains, neck retraction, dysphagia, and hepatosplenomegaly; the juvenile form features a slowly progressive loss of intellect, hepatosplenomegaly, ataxia, myoclonic seizures, and spasticity; the neuronopathic forms are characterized by neuronal loss with neuronophagia, and accumulation of glucocerebroside in neurons.
- Gaucher's disease is a rare, inherited disorder that causes too much of a substance called glucocerebroside to build up in your spleen, liver, lungs, bones and sometimes in your brain. The buildup prevents these organs from working properly.there are three types:
- type 1, the most common form, causes liver and spleen enlargement, bone pain and broken bones, and, sometimes, lung and kidney problems. It does not involve the brain. It can occur at any age.
- type 2, which causes severe brain damage, appears in infants. Most children who have it die by age 2.
- in type 3, there may be liver and spleen enlargement, and signs of brain involvement appear gradually.
gaucher's disease has no cure. Treatment options for types 1 and 3 include medicine and enzyme replacement therapy, which is usually very effective. There is no good treatment for the brain damage of type 2.
ICD-10-CM E75.22 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):- 642 Inborn and other disorders of metabolism
What are the symptoms of Gaucher disease?- Enlarged spleen.
- Enlarged liver.
- Eye movement disorders.
- Yellow spots in the eyes.
- Not having enough healthy red blood cells (anemia)
- Extreme tiredness (fatigue)
- Bruising.
- Lung problems.
- Type 1. This is the most common type of Gaucher disease. It affects about 90% of people with the disease. If you have type 1, you don’t have enough platelets in your blood. This can make you bruise easily and feel very tired (fatigued). Your symptoms can start at any age. You might have an enlarged liver or spleen. You may also have kidney, lung, or skeletal problems.
- Type 2. This form of the disease affects babies by age 3 to 6 months. It is fatal. In most cases children don’t live beyond 2 years old.
- Type 3. Symptoms include skeletal problems, eye movement disorders, seizures that become more obvious over time, blood disorders, breathing problems, and liver and spleen enlargement.
- An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (glucosylceramidase) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the mononuclear phagocyte system. The characteristic gaucher cells, glycosphingolipid-filled histiocytes, displace normal cells in bone marrow and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.
- An inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia.
- Autosomal recessive disorder caused by deficiency of the enzyme glucocerebrosidase featuring the pathological storage of glycosylceramide in mononuclear phagocytes; the most common subtype is the non-neuronopathic form, a slowly progressive condition characterized by hepatosplenomegaly and skeletal deformities; the neuronopathic forms are divided into infantile and juvenile forms; the infantile form presents at 4-5 months of age with anemia, loss of cognitive gains, neck retraction, dysphagia, and hepatosplenomegaly; the juvenile form features a slowly progressive loss of intellect, hepatosplenomegaly, ataxia, myoclonic seizures, and spasticity; the neuronopathic forms are characterized by neuronal loss with neuronophagia, and accumulation of glucocerebroside in neurons.
- Gaucher's disease is a rare, inherited disorder that causes too much of a substance called glucocerebroside to build up in your spleen, liver, lungs, bones and sometimes in your brain. The buildup prevents these organs from working properly.there are three types:
- type 1, the most common form, causes liver and spleen enlargement, bone pain and broken bones, and, sometimes, lung and kidney problems. It does not involve the brain. It can occur at any age.
- type 2, which causes severe brain damage, appears in infants. Most children who have it die by age 2.
- in type 3, there may be liver and spleen enlargement, and signs of brain involvement appear gradually.
- 642 Inborn and other disorders of metabolism
- Enlarged spleen.
- Enlarged liver.
- Eye movement disorders.
- Yellow spots in the eyes.
- Not having enough healthy red blood cells (anemia)
- Extreme tiredness (fatigue)
- Bruising.
- Lung problems.
Comments
Post a Comment